IP Library › Granted Patent US 11,970,488
Granted Patent B1
US 11,970,488 · App. 18/379,966 · Granted Apr 30, 2024

2-(benzo[d]thiazol-2-yl)-N'-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide as an antimicrobial compound

Inventors: Hany Mohamed Abd El-Lateef Ahmed (Al-Ahsa, SA); Mai Mostafa Khalaf Ali (Al-Ahsa, SA); Antar Ahmed Abdelhamid Ahmed (Sohag, EG); Amer A. Amer (Sohag, EG)
Assignee: KING FAISAL UNIVERSITY
C07D417/12A61P31/04A61P31/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,970,488
App. No.
18/379,966
Granted
Apr 30, 2024
Kind
B1
Abstract

A 2-(benzo[d]thiazol-2-yl)-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide compound, its synthesis, and its use as an antimicrobial agent.

Claims (3)

1. A 2-(benzo[d]thiazol-2-yl)-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide compound having the formula I:

2. The 2-(benzo[d]thiazol-2-yl)-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide compound of claim 1 , wherein the compound is obtained as crystals.

3. A pharmaceutically acceptable composition comprising a therapeutically effective amount of the 2-(benzo[d]thiazol-2-yl)-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide compound of claim 1 and a pharmaceutically acceptable carrier.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2023
From: AHMED, HANY MOHAMED ABD EL-LATEEF; ALI, MAI MOSTAFA KHALAF; AHMED, ANTAR AHMED ABDELHAMID; AMER, AMER A.
To: KING FAISAL UNIVERSITY
Reel/Frame 065223/0020 →